Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Some groups, however, including Black and Latino men and homeless people, are not faring as well as others.
Researchers are working on patches containing tiny needles that deliver medications through the skin.
Six presidential candidates answered 15 questions posed by a coalition of more than 50 AIDS groups.
Nonetheless, DC has seen remarkable progress against its epidemic since the mid-2000s.
Honoring 30 Years at NMAC
Two HIV researchers discuss their recent books on gay men and HIV-positive women.
A roundup of POZ’s reporting on studies presented at the Mexico City conference about HIV treatment, vaccines, PrEP and other concerns.
Three counties in the state are among 48 nationwide eligible for federal HIV resources. Here’s what’s fueling new cases in these regions.
Evidence supports new PrEP option for gay men and trans women, but there’s no consensus for other groups.
Who got what and why? NMAC’s Paul Kawata addresses criticism and breaks down the data.
Changes to the Title X program concern abortion and target Planned Parenthood. But they should alarm the HIV community.
The chairs of the HIV Medicine Association and the American Academy of HIV Medicine urge health care advice from clinicians, not lawyers.
How true is his statement? These facts add context.
On-demand, or 2-1-1, PrEP requires taking only four doses of Truvada during the days surrounding sex.
Researchers provided an initial Truvada prescription to eligible gay and bi men and trans women at their first appointment.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.